Stock Analysis

IHH Healthcare Berhad Third Quarter 2024 Earnings: EPS: RM0.061 (vs RM0.06 in 3Q 2023)

KLSE:IHH
Source: Shutterstock

IHH Healthcare Berhad (KLSE:IHH) Third Quarter 2024 Results

Key Financial Results

  • Revenue: RM5.74b (down 3.1% from 3Q 2023).
  • Net income: RM534.0m (flat on 3Q 2023).
  • Profit margin: 9.3% (up from 9.0% in 3Q 2023).
  • EPS: RM0.061 (up from RM0.06 in 3Q 2023).
earnings-and-revenue-history
KLSE:IHH Earnings and Revenue History November 29th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

IHH Healthcare Berhad Earnings Insights

Looking ahead, revenue is forecast to grow 7.3% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Healthcare industry in Malaysia.

Performance of the Malaysian Healthcare industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

You still need to take note of risks, for example - IHH Healthcare Berhad has 1 warning sign we think you should be aware of.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.